PROQR THERAPEUTICS N

PRQR
Real-time Estimate Quote. Real-time Estimate  - 11/23 10:56:36 am
4.425USD +5.36%
Prev.4.2000
Open4.2500
High4.4200
Low4.2300
Volume832 294
Latest news
5d ago
7d ago
11/02
10/05
Chart PROQR THERAPEUTICS N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance4,354,855,47
Spread/Res.-0,80%-11%-21%
Spread/Supp.17%17%17%
Support3,693,693,69
Financials
Sales 2020 10,5 M - -
Net income 2020 -53,0 M - -
Net Debt 2020 - - -
P/E ratio 2020 -4,07x
Yield 2020 -
Capitalization 211 M 211 M -
Capi. / Sales 2020 20,1x
Capi. / Sales 2021 64,7x
Nbr of Employees -
Free-Float 90,0%
Company
ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-03-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 5
Average target price 21,67 $
Last Close Price 4,20 $
Spread / Highest target 686%
Spread / Average Target 416%
Spread / Lowest Target 257%